C12Y 301/01023
Acylglycerol lipase
Official title: Acylglycerol lipase (3.1.1.23)
C12Y301/01023 (Acylglycerol lipase) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 7
- Assignees
- 7
- Inventors
- 15
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Triglycerides and structured lipids from short- and medium-chain fatty acids6 Jan 2026US 12,516,358 B2BioVeritas, LLC
- Compositions and methods for modulating ABHD2 activity15 Mar 2022US 11,273,167 B2The Regents of the University of California
- Method for treatment of liver steatosis or non-alcoholic fatty liver by using 2-monoacylglycerol cleaving enzyme14 Sep 2021US 11,116,822 B2Industry-Academic Cooperaton Foundation, Yonse: University
- Radiolabeled monoacylglycerol lipase occupancy probe5 Nov 2019US 10,463,753 B2Lundbeck La Jolla Research Center, Inc.
- Triglycerides and structured lipids from short- and medium-chain fatty acids16 Jul 2026US 2026/0201429 A1BioVeritas, LLC
- Process for preparation of phloroglucinol and phenolic derivatives31 Oct 2024US 2024/0360485 A1
- Triglycerides and Structured Lipids from Short- and Medium-Chain Fatty Acids24 Oct 2024US 2024/0352492 A1BioVeritas, LLC
- Method for treatment of liver steatosis or non-alcoholic fatty liver by using 2-monoacylglycerol cleaving enzyme21 Nov 2019US 2019/0351030 A1Industry-Academic Cooperation Foundation, Yonsei University
- Radiolabeled monoacylglycerol lipase occupancy probe14 Feb 2019US 2019/0046668 A1Abide Therapeutics, Inc.
Most cited
By later US patents